About this trial
To verify the effectiveness and safety of minimally invasive coronary artery bypass grafting for complete revascularization of multivessel coronary artery disease via inferior part-sternotomy, We aim to randomize 260 patients undergoing isolated Coronary artery bypass grafting (CABG) to compare the ratios of complete revascularization between inferior part-sternotomy CABG and full median sternotomy CABG from 9 hospitals in China.
Eligibility criteria
Qualifiers
None
Disqualifiers
Single vessel disease, double vessel disease, left main artery disease without right coronary artery disease.
Concomitant cardiac surgeries(i.e. valve repair or replacement, Maze surgery, left ventricular repair due to ventricular aneurysm).
Redo CABG.
Emergent CABG.
Trial design
Treatments tested in this trial
- Inferior part-sternotomy
- Full median sternotomy
Treatment groups
Locations
Sponsors and collaborators
China National Center for Cardiovascular Diseases
Lead sponsor
Tangshan Central Hospital
Collaborator
Baotou Central Hospital
Collaborator
Xiamen Second Hospital
Collaborator
Beijing Shijitan Hospital, Capital Medical University
Collaborator
Peking University International Hospital
Collaborator
Shenzhen Sun Yat-sen Cardiovascular Hospital
Collaborator
Fuwai Yunnan Cardiovascular Hospital
Collaborator
Henan Provincial People's Hospital
Collaborator